Innovation Pharmaceuticals Inc (IPIX)

[Papaul21]

I don't know where you see OM
The non-binding term sheet also includes a Right of First Refusal for rights to Brilacidin for the treatment of more extensive forms of Inflammatory Bowel Disease, such as Ulcerative Colitis and Crohn’s Disease, and a Right of First Negotiation for rights to Brilacidin in other Gastrointestinal (GI) indications.
They never speak about OM, that's the good new. I think we probably see a type of PR like this one soon for OM.